Free tool
FAERS Monitor: Sulfatrim
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018615 or its brand name (Sulfatrim, Sulfamethoxazole, Trimethoprim). Reports on generic versions are filed under their own applications.
Reports
17,270
Serious
15,552
90% of reports
Hospitalization
8,525
Death reported
3,240
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use2,335
- pyrexia2,299
- fatigue2,115
- dyspnoea2,078
- drug ineffective1,979
- rash1,951
- pain1,908
- arthralgia1,652
- pruritus1,643
- infection1,620
- hypersensitivity1,570
- joint swelling1,541
- sinusitis1,495
- weight increased1,487
- diarrhoea1,441
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 40 |
| 2005 | 60 |
| 2006 | 36 |
| 2007 | 195 |
| 2008 | 349 |
| 2009 | 556 |
| 2010 | 542 |
| 2011 | 775 |
| 2012 | 541 |
| 2013 | 130 |
| 2014 | 299 |
| 2015 | 621 |
| 2016 | 693 |
| 2017 | 533 |
| 2018 | 889 |
| 2019 | 1,145 |
| 2020 | 1,490 |
| 2021 | 1,904 |
| 2022 | 1,411 |
| 2023 | 1,317 |
| 2024 | 1,696 |
| 2025 | 1,274 |
| 2026 | 774 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,889 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| sinusitisSignal | 1,495 | 18.0 | 17.2 | 23,773 |
| joint swellingSignal | 1,541 | 15.7 | 15.0 | 21,100 |
| infectionSignal | 1,620 | 13.8 | 13.1 | 19,096 |
| hypersensitivitySignal | 1,570 | 10.4 | 9.9 | 13,304 |
| pyrexiaSignal | 2,299 | 8.1 | 7.8 | 14,533 |
| weight increasedSignal | 1,487 | 8.1 | 7.7 | 9,335 |
| rashSignal | 1,951 | 5.5 | 5.2 | 7,242 |
| pruritusSignal | 1,643 | 5.2 | 5.0 | 5,689 |
| arthralgiaSignal | 1,652 | 4.9 | 4.6 | 5,133 |
| dyspnoeaSignal | 2,078 | 4.5 | 4.3 | 5,755 |
| painSignal | 1,908 | 3.8 | 3.6 | 4,024 |
| fatigueSignal | 2,115 | 3.3 | 3.2 | 3,538 |
| off label useSignal | 2,335 | 3.3 | 3.1 | 3,791 |
| diarrhoeaSignal | 1,441 | 2.7 | 2.6 | 1,615 |
| drug ineffective | 1,979 | 1.8 | 1.8 | 793 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.